Extent of resection and role of adjuvant treatment in resected localized breast angiosarcoma

Background Localized breast angiosarcoma (LBA) is a rare condition with no prospective clinical trials guiding the management of afflicted patients. Management of LBA and the resulting outcomes on a nationwide scale has not been previously examined.